Rossari Biotech Limited, a speciality chemicals manufacturer providing intelligent and sustainable solutions for customers across industries, has posted a solid growth of 16% YoY in Q2 FY21 whereby the total revenue stood at Rs. 171.7 crore. 

 

EBITDA at Rs. 30.1 crore as against Rs. 28.3 crore in Q2 FY20. Net profit stood at Rs. 20.7 crore as against Rs. 17.7 crore in Q2 FY20. 

 

Commenting on the performance for the quarter, Edward Menezes, Promoter & Executive Chairman and Sunil Chari, Promoter & Managing Director, said, “We are pleased to share that we have delivered a robust performance during the quarter driven by improved demand and traction across businesses. Our HPPC business continues to record healthy growth as we were one of the early movers to tap upon the growing national demand for hygiene products and anti-viral portfolio sales. Our fungible & agile manufacturing establishments enabled us to swiftly and efficiently address large volume requirements for these products, which in turn, recorded strong improvement in HPPC sales." 

 

"Our focus towards seeding new business products with distinguished offerings and unique value remains solid. During the quarter, we have further broadened our product offerings within the high-growth categories of hygiene, laundry and fabric-care segments. On the operational front, our manufacturing facilities are also now operating at near-normal utilization levels. In addition, the ramp-up at our greenfield Dahej plant is continuing at a healthy pace and we remain on track to fully operationalise the plant by March 2021," added Memezes and Chari. 

 

On the whole, the company has delivered a steady and encouraging performance during the first half of the fiscal. As we look ahead, the upcoming festive season and the stabilization in domestic markets should lead to better demand and enhanced consumer sentiments in the medium to longer term. On the whole, we are confident of the future growth potential and opportunities across the domestic market over the medium to longer term.”